JBIO (aerovatetx.com) Sof foyda

JBIO (aerovatetx.com) - kompaniyaning tovar belgisi

Aerovate Therapeutics Inc (JBIO) uchun ushbu kunlik narxlar grafigi hozirda -0.14 darajasida baholangan foyda dinamikasini aks ettiradi. Biznes o'pka gipertoniyasi uchun davolash vositalarini ishlab chiqishga e'tibor qaratgan bo'lib, patent himoyasi va past sintez xarajatlari hisobiga global daromadlarni kutmoqda. Biroq, kompaniya hozirda klinik sinovlar va strategik tahlil bosqichida bo'lib, barqaror foyda oqimlariga ega emas va faqat mavjud rezervlarga tayanmoqda.

JBIO (Aerovate Therapeutics Inc) Sof foyda tarixi 30.04.2025dan 01.11.2026gacha

aerovatetx.com (JBIO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Aerovate Therapeutics|JBIO - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi JBIO|JBIO - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Aerovate Therapeutics Inc|JBIO - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi aerovatetx.com|JBIO - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aerovate Therapeutics Inc|JBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics|JBIO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar JBIO|JBIO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Aerovate Therapeutics Inc|Shoshilinch likvidlik aerovatetx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
JBIO - Sof foyda
Kompaniyaning jamlanma tahlili:Aerovate Therapeutics Inc
Aerovate Therapeutics, Inc. asosiy tovari

Sof foyda barcha operatsion va soliq xarajatlari chegirib tashlangangandan keyingi yakuniy moliyaviy natijani aks ettiradi. Investorlar biznes kapitalizatsiyasi tezligini va uning monetar zarbalarga chidamliligini baholash uchun ushbu metrikan tahlil qiladilar. Sof foyda darajalaridagi tendentsiya ichki resurslarni boshqarish samaradorligini aniqlash imkonini beradi. Aerovate Therapeutics Inc (JBIO) uchun ushbu ko'rsatkich R&D dan ikkinchi darajali hisoblanadi. O'pka gipertenziyasi uchun dori vositasini ishlab chiqishning muvaffaqiyati bozor sikllariga qaraganda klinik ma'lumotlarga bog'liqdir.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR: Sof foyda|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|IMNM: Yakuniy foyda|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV - Kompaniyaning sof daromadi|Septerna Inc - Sof daromad|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|RIGL - Sof foyda|ANAB (AnaptysBio Corp) - Sof daromad|ATXS: Soliqlar to‘langandan keyingi foyda|ENGN (enGene Holdings Inc.) - Sof foyda|Kompaniyaning sof daromadi rapt.com RAPT|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Tiziana Life Sciences PLC - Sof daromad|Soliqlar to‘langandan keyingi foyda CABA (Cabaletta Bio Inc)|Ventyx Biosciences - Sof foyda|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|Kompaniyaning sof daromadi Eledon Pharmaceuticals Inc. (ELDN)|Kompaniyaning sof foydasi Agenus Inc|CLYM: Yakuniy foyda|Sof foyda ZURA|Sof foyda atyrpharma.com (ATYR)|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA (ImageneBio) - Soliqdan keyingi foyda|Shattuck Therapeutics - Sof foyda|Kompaniyaning sof daromadi Equillium, Inc.|CNTB (connectbiopharm.com) - Sof daromad|Immunic (IMUX) - Sof foyda|Sof daromad ATRA|IFRX (InflaRx GmbH) - Soliqlar to‘langandan keyingi foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Sof foyda CELU (Celularity)|INMB - Sof daromad|BRNS - Kompaniyaning sof foydasi|Sof moliyaviy natija Kezar Life Sciences Inc. KZR|SABS (SAB Biotherapeutics, Inc) - Sof daromad|Akari Therapeutics, Plc - Yakuniy foyda|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Q32 Bio Corp (QTTB) - Sof moliyaviy natija|Kompaniyaning sof foydasi GeoVax (GOVX)|Edesa Biotech Inc - Kompaniya foydasi|Sof foyda IBIO (iBio Corp)|CARM - Sof daromad|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics - Soliqlar to‘langandan keyingi foyda|HCWB: Sof foyda|APVO (Aptevo Therapeutics Inc.) - Kompaniyaning sof foydasi|AIM (AIM ImmunoTech) - Sof foyda|Aditxt Corp (ADTX) - Sof moliyaviy natija|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|XRTX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB (Revelation Biosciences Inc) - Soliqdan keyingi foyda|Indaptus - Sof foyda|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Kompaniyaning sof foydasi Allakos Inc|HOOK: Yakuniy foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof foyda tcbiopharm.com TCBP|THRD: Sof daromad